DiaMedica Therapeutics (DMAC) Times Interest Earned (2024 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Times Interest Earned came in at 455.74 in Q1 2026, up 94.4% on a YoY basis from 234.43 in Q1 2025, and up 94.4% quarter-over-quarter from 8144.0 in Q1 2025.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Times Interest Earned (2024 - 2026) Analysis & Trends
DiaMedica Therapeutics (DMAC) has reported Times Interest Earned for 3 consecutive years, with 455.74 the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.86 Bn | 192.87 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.52 Bn | 176.34 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 131.47 Bn | 123.62 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 61.16 Bn | 55.98 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 53.15 Bn | 48.02 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.20 Bn | 29.89 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.65 Bn | 30.37 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.30 Bn | 29.30 Bn | 1.16 Mn | - |
| 10 | DiaMedica Therapeutics | 346.54 Mn | 346.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -455.74 |
| Mar 31, 2025 | -8,144.00 |
| Mar 31, 2024 | -302.16 |